MARY GONZALES: Open Payments
NPI 1659687580 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$15,699 in 122 payments from 27 companies in 2025. Trend: 2023 $28,110 · 2024 $14,425 · 2025 $15,699
Speaker / faculty: $10,735Food & beverage: $2,927Travel & lodging: $2,036
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 41 | $13,977 |
| ViiV Healthcare Company | 26 | $653 |
| ABBVIE INC. | 12 | $160 |
| Madrigal Pharmaceuticals | 1 | $114 |
| Merck Sharp & Dohme LLC | 6 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $79 |
| Abbott Laboratories | 3 | $71 |
| Napo Pharmaceuticals Inc | 2 | $58 |
| PFIZER INC. | 3 | $44 |
| Janssen Biotech, Inc. | 2 | $41 |
Products named: Biktarvy, CABENUVA, APRETUDE, RUKOBIA, REZDIFFRA, PIFELTRO, CAPLYTA, FREESTYLE LIBRE 3.
Industry payments across KS — which companies pay providers there.
